Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takeshi Masuda

Showing results (201-210 of 298) with videos related to

Pageof 30
Sort By:
Medicine|February 20, 2021
A machine-learning based approach to quantify fine crackles in the diagnosis of interstitial pneumonia: A proof-of-concept studyYasushi Horimasu, Shinichiro Ohshimo, Kakuhiro Yamaguchi, et al.
Cancer Letters|November 4, 2018
Anti-KL-6/MUC1 monoclonal antibody reverses resistance to trastuzumab-mediated antibody-dependent cell-mediated cytotoxicity by capping MUC1Masashi Namba, Noboru Hattori, Hironobu Hamada, et al.
Free Radical Biology & Medicine|April 2, 2019
Suplatast tosilate reduces radiation-induced lung injury in mice through suppression of oxidative stressYusuke Izumi, Taku Nakashima, Takeshi Masuda, et al.
Medicine|January 9, 2020
Pulmonary arteriovenous malformation exhibiting recanalization >10 years after coil embolization: Two case reportsShun Takao, Takeshi Masuda, Takahiro Yamada, et al.
Journal of Cellular and Molecular Medicine|February 9, 2019
Inhibition of PAI-1 limits chemotherapy resistance in lung cancer through suppressing myofibroblast characteristics of cancer-associated fibroblastsTakeshi Masuda, Taku Nakashima, Masashi Namba, et al.
Respiratory Research|June 13, 2020
Reduced endogenous secretory RAGE in blood and bronchoalveolar lavage fluid is associated with poor prognosis in idiopathic pulmonary fibrosisKakuhiro Yamaguchi, Hiroshi Iwamoto, Witold Mazur, et al.
Geriatrics & Gerontology International|August 11, 2021
Efficacy of erlotinib and its effects on the quality of life of older patients with epidermal growth factor receptor-mutant non-small cell lung cancer: A prospective, multicenter, dose-modification studyYukari Tsubata, Takeshi Masuda, Kosuke Hamai, et al.
Respiratory Investigation|November 23, 2025
Incidence and clinical features of venous thromboembolism in patients with lung cancer in Japan: results from the CS-Lung-003 prospective observational registry studyYukari Tsubata, Nobuhiro Kanaji, Mika Nakao, et al.
EMBO Reports|August 3, 2023
SETD1A function in leukemia is mediated through interaction with mitotic regulators BuGZ/BUB3Sarah Perlee, Sota Kikuchi, Tomoyoshi Nakadai, et al.
Molecular Cancer Therapeutics|November 6, 2025
Plasminogen Activator Inhibitor-1 Mediates Tolerance to Anti-PD-1 Immunotherapy in Non-Small Cell Lung CancerMasahiko Sumii, Takeshi Masuda, Kiyofumi Shimoji, et al.
Pageof 30

Showing results (201-210 of 298) with videos related to

Sort By:
Pageof 30
Medicine|February 20, 2021
A machine-learning based approach to quantify fine crackles in the diagnosis of interstitial pneumonia: A proof-of-concept studyYasushi Horimasu, Shinichiro Ohshimo, Kakuhiro Yamaguchi, et al.
Cancer Letters|November 4, 2018
Anti-KL-6/MUC1 monoclonal antibody reverses resistance to trastuzumab-mediated antibody-dependent cell-mediated cytotoxicity by capping MUC1Masashi Namba, Noboru Hattori, Hironobu Hamada, et al.
Free Radical Biology & Medicine|April 2, 2019
Suplatast tosilate reduces radiation-induced lung injury in mice through suppression of oxidative stressYusuke Izumi, Taku Nakashima, Takeshi Masuda, et al.
Medicine|January 9, 2020
Pulmonary arteriovenous malformation exhibiting recanalization >10 years after coil embolization: Two case reportsShun Takao, Takeshi Masuda, Takahiro Yamada, et al.
Journal of Cellular and Molecular Medicine|February 9, 2019
Inhibition of PAI-1 limits chemotherapy resistance in lung cancer through suppressing myofibroblast characteristics of cancer-associated fibroblastsTakeshi Masuda, Taku Nakashima, Masashi Namba, et al.
Respiratory Research|June 13, 2020
Reduced endogenous secretory RAGE in blood and bronchoalveolar lavage fluid is associated with poor prognosis in idiopathic pulmonary fibrosisKakuhiro Yamaguchi, Hiroshi Iwamoto, Witold Mazur, et al.
Geriatrics & Gerontology International|August 11, 2021
Efficacy of erlotinib and its effects on the quality of life of older patients with epidermal growth factor receptor-mutant non-small cell lung cancer: A prospective, multicenter, dose-modification studyYukari Tsubata, Takeshi Masuda, Kosuke Hamai, et al.
Respiratory Investigation|November 23, 2025
Incidence and clinical features of venous thromboembolism in patients with lung cancer in Japan: results from the CS-Lung-003 prospective observational registry studyYukari Tsubata, Nobuhiro Kanaji, Mika Nakao, et al.
EMBO Reports|August 3, 2023
SETD1A function in leukemia is mediated through interaction with mitotic regulators BuGZ/BUB3Sarah Perlee, Sota Kikuchi, Tomoyoshi Nakadai, et al.
Molecular Cancer Therapeutics|November 6, 2025
Plasminogen Activator Inhibitor-1 Mediates Tolerance to Anti-PD-1 Immunotherapy in Non-Small Cell Lung CancerMasahiko Sumii, Takeshi Masuda, Kiyofumi Shimoji, et al.
Pageof 30